Immunome, Inc.
IMNM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $143 | $99 | $20 | $49 |
| Short-Term Investments | $74 | $39 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $6 | $1 | $3 |
| Total Curr. Assets | $221 | $145 | $23 | $57 |
| Property Plant & Equip (Net) | $14 | $4 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $0 | $0 | $0 |
| Total NC Assets | $19 | $4 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $240 | $149 | $24 | $58 |
| Liabilities | – | – | – | – |
| Payables | $14 | $3 | $2 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $10 | $0 | $0 |
| Other Curr. Liab. | $33 | $8 | $5 | $6 |
| Total Curr. Liab. | $54 | $22 | $7 | $10 |
| LT Debt | $5 | $1 | $0 | $0 |
| Deferred Rev, NC | $0 | $5 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | -$5 | $0 | $0 |
| Other NC Liab. | $0 | $5 | $0 | $0 |
| Total NC Liab. | $5 | $7 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $2 | $0 | $0 |
| Total Liabilities | $59 | $29 | $7 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $58 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$516 | -$223 | -$116 | -$79 |
| AOCI | $0 | $0 | $0 | -$58 |
| Other Equity | $697 | $343 | $133 | $127 |
| Total Equity | $181 | $120 | $17 | $48 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $240 | $149 | $24 | $58 |
| Net Debt | -$139 | -$97 | -$20 | -$49 |